Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Induces DNA crosslinks, challenging the FA pathway, thereby indirectly affecting FANCG function. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Forms DNA adducts leading to crosslinks, requiring FA pathway intervention, indirectly impacting FANCG activity. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
PARP inhibitor, impacts DNA repair mechanisms, potentially influencing the FA pathway and indirectly FANCG. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $178.00 $270.00 $712.00 | 3 | |
Another PARP inhibitor, alters DNA repair processes, indirectly affecting FA pathway and FANCG function. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
PARP inhibitor, affects DNA repair, could indirectly influence FANCG through the FA pathway. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
PARP inhibitor, may indirectly impact FANCG by affecting DNA repair pathways. | ||||||
Carboplatin | 41575-94-4 | sc-202093 sc-202093A | 25 mg 100 mg | $47.00 $132.00 | 14 | |
Similar to cisplatin, forms DNA crosslinks, indirectly challenging FANCG through the FA pathway. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $110.00 $386.00 | 8 | |
Platinum-based compound causing DNA crosslinks, affecting FA pathway and thus FANCG indirectly. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
Inhibits ATR kinase, a key player in DNA damage response, potentially influencing FA pathway and FANCG. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
Inhibits CHK1, a kinase involved in DNA damage response, possibly affecting FA pathway and indirectly FANCG. | ||||||